Latest News
EU-LIFE statement on the final Multi Annual Financial Framework agreement
14/12/2020
EU-LIFE congratulates the European leaders on the agreement reached for the EU 2021-2027 Multiannual Financial Framework (MFF) Programme, which is crucial for Europe to move forward.
Post-BREXIT: EU-LIFE urges both sides to reach a deal in Research & Innovation
25/11/2020
The EU-LIFE community continues to join forces with researchers, innovators, policy makers and all relevant actors across the European continent to enable the best science and ensure the transformation of scientific achievements into improvements in peoples’ lives. We can only do this well with our partners from the United Kingdom.
Reaction of EU-LIFE alliance on the next framework programme budget agreement
16/11/2020
On 10th November, the European Council, the European Commission (EC) and the European Parliament reached a historic agreement on the budget for the next seven years, the Multiannual Framework Programme (MFF), to be formally approved later this year.
Deal for EU seven-year budget: how to best allocate top up Horizon Europe
11/11/2020
The European Parliament. the European Commission’s and EU Council’s negotiating teams finally agreed yesterday on the Multiannual Financial Framework of 2021-27. This is an important step to ensure that there will be no gap in European funding when the current multiannual financial framework ends in January 2021.
Professor Nektarios Tavernarakis, Research Director at the Institute of Molecular Biology and Biotechnology (IMBB), elected Vice President of the European Research Council
09/11/2020
Today, Nektarios Tavernarakis, Research Director at the IMBB-FORTH, an Associate Partner of EU-LIFE, was unanimously elected Vice President of the European Research Council (ERC).
EU-LIFE reaction to the European Commission communication on the new ERA
14/10/2020
EU-LIFE welcomes the European Commission communication and expresses its strong support to the strategic objectives and actions for a new and strengthened European Research Area and states below its first reaction.
Reaction of EU-LIFE alliance on Horizon Europe’s Cancer Mission
28/9/2020
EU-LIFE, the alliance of leading independent research institutes in the life sciences, hereby presents its response to the Cancer mission draft.
LifeTime: improving European healthcare through cell-based interceptive medicine
14/9/2020
LifeTime initiative is developing a fundamentally new approach to understanding the constant changes within cells and their relationships, thus creating the foundation for the precision medicines of the future.
